Flow cytometric assays for quantifying polymorphonuclear leucocyte (PMN) function involve peripheral blood fractionation methods. However, most are of limited use for conditions like pediatrics and thalassemia, as they may require large blood volumes or complicated by red blood cell contamination. In whole blood assay, 500-ll aliquots of normal or thalassemic whole blood were incubated with bis-carboxyethyl-carboxyfluorescein pentaacetoxymethylester (BCECF-AM)-labeled Candida albicans cells and phycoerythrin-conjugated anti-CD13 monoclonal antibody for PMNs. Phagocytosis was quantitated by gating on CD13 label PMNs and determining the frequency of phagocytosed yeast using flow cytometry. The killing activity was quantitated by estimating the number of viable fluorescence retaining yeast cells liberated following lysis of PMNs. In normal control or thalassemia samples, nonphagocytosed yeast and PMNs with or without phagocytosed yeast were readily distinguished by two-color dot plot, permitting phagocytosis estimates. Viable and nonviable yeast killed by whole blood PMNs were distinguished by side scatter and fluorescence, permitting killing estimates. The patterns seen using whole blood was similar to that seen with fractionated PMNs. Data from thalassemia patients showed similar opsonophagocytosis but slightly decreased intracellular killing of yeast cells when compared with normal subjects. This assay provides an alternative method to assess PMN function in small blood samples, which could be especially useful in conditions like thalassemia and pediatric patients. '
International Society for Analytical CytologyKey terms bis-carboxyethyl-carboxyfluorescein pentaacetoxymethylester; Candida albicans; flow cytometry; phagocytes; phagocytosis; polymorphonuclear leucocytes; thalassemia NEUTROPHILS, also called polymorphonuclear leucocytes (PMNs), are first-line defenses against invading microorganisms. Various flow cytometric or whole blood fractionation methods exist to assess PMN function (1-8), but most require relatively large numbers of PMNs, making them impractical for pediatric blood samples. In addition, the assays perform poorly on samples from patients with hematological conditions such as thalassemia. Moreover, fractionating PMNs from blood is time consuming and the procedure used can itself trigger PMN activation.Whole blood assays are simple, convenient, and generally require small volumes. Here, we describe a rapid, simple, and reliable flow cytometric technique for measuring opsonophagocytosis and killing of Candida albicans (C. albicans) by PMNs using a whole blood assay. In efforts to validate the technique, PMNs derived from whole blood samples and, for purposes of comparison, dextran fractionation preparations contaminated with non-PMNs were assayed for PMN function using our whole blood assay utilizing blood samples from patients with thalassemia, an inherited autosomal recessive hemolytic anemia associated with impaired globin chain synthesis. PMN fractionation by the dextran sedimentat...